Federal Circuit Upholds Patent Invalidity Ruling In Drug Dispute

Federal Circuit Upholds Patent Invalidity Ruling In Drug Dispute

WASHINGTON, D.C. - Finding that there is no genuine issue of material fact that the shared specification of two patents do not enable one of ordinary skill to practice certain claims without undue experimentation, the Federal Circuit U.S. Court of Appeals on June 26 affirmed a finding of patent invalidity for lack of enablement (Wyeth and Cordis Corporation v. Abbott Laboratories et al., Nos. 12-1223, 1224, Fed. Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®